2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on AML: Is Anti-CD47 Antibody Magrolimab + Azacitidine Effective and Well Tolerated in TP53-mutant AML?

23 views
July 22, 2020
Comments 0
Login to view comments. Click here to Login